Theranostics represent a significant leap forward in precision medicine, offering hope to patients who may have exhausted traditional cancer treatment options.
Theranostics uses radioactive pharmaceutical agents to:
- Locate cancer anywhere in the body through advanced imaging.
- Deliver radiation only to cancerous cells, sparing healthy tissue.
We offer lutetium Lu 177 vipivotide tetraxetan, one of the most promising new targeted radiopharmaceutical therapies for advanced prostate cancer. This cutting-edge therapy uses radioactive molecules to find and destroy cancer cells with precision.
Learn more about theranostics at Mayo Clinic in Florida here.